by TractManager | Jun 30, 2016 | Health Technology Assessment
Purpose of Technology: Patients with chronic myelogenous leukemia (CML) overproduce partially mature, abnormal white blood cells of the myeloid lineage. Allogeneic hematopoietic stem cell transplantation (HSCT) is a procedure in which patients undergo high-dose...
by TractManager | Jun 30, 2016 | Health Technology Assessment
Purpose of Technology: Noninvasive electrical bone growth stimulators (EBGS) are external devices that deliver electrical energy to a fracture or bone fusion site. The goal is to induce osteogenesis, stimulate bone growth, and promote healing of fresh, delayed, or...
by TractManager | Jun 29, 2016 | Emerging Technology Report
Epclusa is the first FDA-approved pangenotypic regimen for the treatment of chronic hepatitis C virus infection. The fixed-dose combination pill contains sofosbuvir 400 mg and velpatasvir 100 mg. Sofosbuvir is sold separately under the brand name Sovaldi. Velpatasvir...
by TractManager | Jun 23, 2016 | Emerging Technology Report
Health problem: Heart transplantation Technology description: An ex vivo heart perfusion system for portable normothermic perfusion of donor hearts for transplantation. Best available evidence: Single published phase II/III trial. Regulatory status: Under...
by TractManager | Jun 23, 2016 | Molecular Test Assessment
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths in the United States. It is estimated that approximately 134,000 individuals will be diagnosed with CRC in 2016, and approximately 49,000 people will die from the...
Recent Comments